Back to top
more

InMode (INMD)

(Real Time Quote from BATS)

$13.95 USD

13.95
815,489

+0.21 (1.53%)

Updated Aug 4, 2025 03:36 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (173 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

InMode (INMD) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

InMode (INMD) delivered earnings and revenue surprises of +9.30% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Are Options Traders Betting on a Big Move in InMode Stock?

by Zacks Equity Research

Investors need to pay close attention to InMode stock based on the movements in the options market lately.

Zacks Equity Research

Envista (NVST) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

InMode (INMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Do Options Traders Know Something About InMode Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to InMode stock based on the movements in the options market lately.

Zacks Equity Research

Company News for Apr 29, 2025

by Zacks Equity Research

Companies In The News Are: DPZ, RVTY, OPRA, INMD.

Zacks Equity Research

InMode (INMD) Lags Q1 Earnings Estimates

by Zacks Equity Research

InMode (INMD) delivered earnings and revenue surprises of -6.06% and 0.61%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: Envista (NVST) Q1 Earnings Expected to Decline

by Zacks Equity Research

Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline

by Zacks Equity Research

InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock?

by Zacks Equity Research

InMode (INMD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

HCI Group and Boise Cascade have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

HCI Group and Boise Cascade have been highlighted as Zacks Bull and Bear of the Day.

Urmimala Biswas headshot

3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally

by Urmimala Biswas

Three discounted MedTech stocks to gain from the market rebound are PAHC, FMS and INMD.

Zacks Equity Research

Is InMode (INMD) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Do Options Traders Know Something About InMode (INMD) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to InMode (INMD) stock based on the movements in the options market lately.

Zacks Equity Research

InMode (INMD) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

InMode (INMD) delivered earnings and revenue surprises of 22.81% and 0.18%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: InMode (INMD) Q3 Earnings Expected to Decline

by Zacks Equity Research

InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Is InMode (INMD) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Should Value Investors Buy InMode (INMD) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Are Investors Undervaluing InMode (INMD) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

InMode (INMD) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

InMode (INMD) delivered earnings and revenue surprises of 13.33% and 0.29%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Owens & Minor (OMI) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Owens & Minor (OMI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Zynex Inc. (ZYXI) Q2 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Zynex (ZYXI) delivered earnings and revenue surprises of -50% and 3.70%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate InMode (INMD) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

InMode (INMD) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

InMode (INMD) delivered earnings and revenue surprises of 12.50% and 0.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

TG Therapeutics (TGTX) delivered earnings and revenue surprises of -133.33% and 15.59%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?